Company Profile

VALIANT ORGANICS LTD.

NSE : NABSE : 540145ISIN CODE : INE565V01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE2785.00-2.9 (-0.1 % )
PREV CLOSE (Rs.) 2787.90
OPEN PRICE (Rs.) 2787.00
BID PRICE (QTY) 2785.00 (9 )
OFFER PRICE (QTY) 2786.00 (1 )
VOLUME 12062
TODAY'S LOW / HIGH (Rs.)2751.00 2836.95
52 WK LOW / HIGH (Rs.) 884.1 3142.7
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.40
TTM EPS (Rs.) 114.02
P/E Ratio 24.38
Book Value (Rs.) 303.98
Face Value (Rs.) 10
MCap (Rs. in Mn) 33775.43
Price/Earning (TTM) 22.31
Price/Sales (TTM) 5.79
Price/Book (MRQ) 9.15
PAT Margin (%) 23.74
ROCE (%) 45.05
Incorporation Year : 2005

Management Info :

Velji Gogri - Chairman Arvind K Chheda - Managing Director

Registered Office :

Address : 109 Uhyog Kshetra 1st Floor,Mulund Goregaon Link,Road Mulund (W),
Mumbai,
Maharashtra-400080

Phone : 022-6797 6683

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE
NEWS More
04May05-04-2020$Valiant Organics informs about compliance certificate Valiant Organics informs abo

Valiant Organics has informed that it has enclosed the Certificate as per Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the period from 1st October, 2019 to 31st March, 2020 of Jagdish Patel & Co., Company Secretaries in Practice for perusal and record.

The above information is a part of company’s filings submitted to BSE.

Valiant Organics has informed that it has enclosed the Certific..
28Feb02-28-2020$Valiant Organics informs about declaration of interim dividend Valiant Organics informs abo

Valiant Organics has informed that the Board of Directors of the Company at its meeting held on Friday, February 28, 2020 has declared 2nd Interim Dividend @60% Rs. 6/- per Equity Share of Rs. 10 each for the Financial year ended 2019-2020. Record Date for the same is March 12, 2020

The above information is a part of company’s filings submitted to BSE.

Valiant Organics has informed that the Board of Directors of th..
23Dec12-23-2019$Valiant Organics incorporates WOS company Valiant Organics incorporate

Valiant Organics has incorporated Wholly Owned Subsidiary (WOS) company namely ‘Valiant Speciality Chemical’. The company has incorporated WOS to carry out the business of manufactures, producers, processors, buyers, sellers, importers, exporters, and or otherwise dealers in chemicals, within and/or outside India.

Valiant Organics is manufacturer of Chemicals, 4-di chloro phenol, 6-di chloro phenol, para chloro phenol, ortho chloro phenol, 6-tri chloro phenol and anisole.  

Valiant Organics has incorporated Wholly Owned Subsidiary (WOS)..
08Nov11-08-2019$Valiant Organics informs about outcome of board meeting Valiant Organics informs abo

Valiant Organics has informed that the Board of Directors of the company at its meeting held on Friday, November 08, 2019, which commenced at 11:30 AM and concluded at 3.40 pm approved Audited Standalone and Consolidated Financial Results of the Company for half year ended September 30, 2019, along with the Auditors report. Pursuant to regulation 33 of SEBl (Listing obligation and Disclosure Requirements) regulations, 2015, and other applicable requirements, a copy of the Audited financial results of the half year ended September 30, 2019 together with the Auditor's report is annexed. The Company also approved payment of lnterim Dividend for the Financial year 2019-2020, of Rs 5 per share, 50 % on equity shares of Rs 10 each.

The above information is a part of company’s filings submitted to BSE.

Valiant Organics has informed that the Board of Directors of th..
Financials More
Rs. in Millions
QTR ANNUAL 20
Net Profit1385.26
Gross Profit 1791.11
Operating Profit 1930.16
Net Sales 5835.77
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Advanced Enzyme (BSE)
 272.80 (19.99%)
M.Cap ( in Cr)
3046.59
Hester Biosciences (BSE)
 1744.95 (1.01%)
M.Cap ( in Cr)
1483.60
Alembic Pharma (BSE)
 926.00 (1.13%)
M.Cap ( in Cr)
17705.42
Panacea Biotec (BSE)
 196.80 (4.99%)
M.Cap ( in Cr)
1205.41
Suven Pharma (BSE)
 742.20 (0.93%)
M.Cap ( in Cr)
9572.28
Shareholding Pattern More
NON-INSTITUTION 51.91 %
PROMOTERS 47.77 %
MUTUAL FUNDS/UTI 0.32 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes